FOUGERA PHARMS INC Company Profile
✉ Email this page to a colleague
What is the competitive landscape for FOUGERA PHARMS INC, and what generic and branded alternatives to FOUGERA PHARMS INC drugs are available?
FOUGERA PHARMS INC has twenty-nine approved drugs.
Drugs and US Patents for FOUGERA PHARMS INC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fougera Pharms Inc | TAZAROTENE | tazarotene | CREAM;TOPICAL | 211175-001 | Jan 28, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Fougera Pharms Inc | FLUOCINONIDE | fluocinonide | SOLUTION;TOPICAL | 072934-001 | Feb 27, 1995 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Fougera Pharms Inc | FLUOCINOLONE ACETONIDE | fluocinolone acetonide | SOLUTION;TOPICAL | 088167-001 | Dec 16, 1982 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Fougera Pharms Inc | CLINDAMYCIN PHOSPHATE | clindamycin phosphate | SOLUTION;TOPICAL | 064159-001 | Jun 5, 1997 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Fougera Pharms Inc | BETAMETHASONE DIPROPIONATE | betamethasone dipropionate | OINTMENT;TOPICAL | 019141-001 | Sep 4, 1984 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
Fougera Pharms Inc | BETAMETHASONE VALERATE | betamethasone valerate | OINTMENT;TOPICAL | 018865-001 | Aug 31, 1983 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.